PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$8.98
+0.23 (+2.63%)
Open$8.75
Previous Close$8.75
Day High$9.23
Day Low$8.45
52W High$18.31
52W Low$8.03
Volume—
Avg Volume2.08M
Market Cap691.70M
P/E Ratio—
EPS$-1.27
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+465.0% upside
Current
$8.98
$8.98
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 184.97M | 173.93M | 162.51M |
| Net Income | -233,715,526 | 52.15M | 46.06M |
| Profit Margin | -126.4% | 30.0% | 28.4% |
| EBITDA | -168,327,249 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |